Detalhe da pesquisa
1.
Apoptotic epithelial cells control the abundance of Treg cells at barrier surfaces.
Nat Immunol
; 17(4): 441-50, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26855029
2.
Phase I study of napabucasin in combination with FOLFIRI + bevacizumab in Japanese patients with metastatic colorectal cancer.
Int J Clin Oncol
; 26(11): 2017-2024, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34291369
3.
A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetics of Napabucasin Combined with Sorafenib in Japanese Patients with Unresectable Hepatocellular Carcinoma.
Drugs R D
; 23(2): 99-107, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37188895
4.
Effects of a reactive oxygen species generator, napabucasin (BBI608), on tolerability, safety, pharmacokinetics, and QT/QTc interval in healthy volunteers.
Pharmacol Res Perspect
; 9(5): e00874, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34628720
5.
Phase 1 study of napabucasin, a cancer stemness inhibitor, in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 85(5): 855-862, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32236642
6.
A Phase I Study of Napabucasin Plus Paclitaxel for Japanese Patients With Advanced/Recurrent Gastric Cancer.
In Vivo
; 33(3): 933-937, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31028219